|
Nov 27
|
Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa
|
|
Sep 7
|
Krystal Biotech to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
|
|
Aug 8
|
We're Interested To See How Krystal Biotech (NASDAQ:KRYS) Uses Its Cash Hoard To Grow
|
|
Aug 7
|
Krystal Biotech Announces Second Quarter 2023 Financial Results and Operational Highlights
|
|
May 23
|
Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™
|
|
May 22
|
Why Shares of Krystal Biotech Are Rising Monday
|
|
May 22
|
Krystal's (KRYS) Dermatology Drug Gets FDA Nod, Stock Up 10%
|
|
May 22
|
FDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder
|
|
May 22
|
Krystal Biotech Announces $160 Million Private Placement Equity Financing
|